TEDC1 and TEDC2, functions in generating centriolar triplet microtubules, and that this is crucial for the proper formation of centriolar subdomains and the stability of centrioles throughout the cell ...

Institute of Quality Standard and Testing Technology for Agro Products, Chinese Academy of Agricultural Sciences, Beijing 100081, China ...

Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the resultant metabolic disturbance, and without the drawbacks associated with ...

LG Electronics Japan Co., Ltd. announced the new 34-inch UWQHD curved LCD monitor, model 34WR50QK-B, on February 18, 2025. This display is engineered for enhanced productivity and multitasking ...

Share on Pinterest Scientists have found that an antibody treatment prevented a decline in muscle mass and bone density after using GLP-1 drugs. Rob and Julia Campbell/Stocksy Aging and limited ...

CD64 has greater binding activity for holding onto antigen-specific antibodies (which is critical for effective targeting) than any other molecule ... cells have natural antibody-binding molecules ...

Institute for Research in Immunology and Cancer (IRIC) Université de Montréal, Montreal, Quebec H3T 1J4, Canada ...

While fibroblast growth factor 21 (FGF21) analogs have shown promise in clinical trials, their underlying molecular mechanisms remain unclear. A research team led by Prof. Li Yu at the Shanghai ...

Roethlisberger detailed how that early success, while a blessing, also came with downsides. It’s an interesting reflection from him at this stage in his life.

Scholar Rock has submitted its anti-myostatin antibody apitegromab for FDA approval, just months after reporting that it hit its primary endpoint in phase III for spinal muscular atrophy (SMA).

The global Antibody-drug Conjugates Market size was valued at USD 2763.08 million in 2024 and is expected to grow at a CAGR of 3.14% from 2025 to 2033 Browse Detailed TOC of Antibody-drug ...